Advertisement

Index by author

July 01, 1996; Volume 278,Issue 1

A

  1. Abran, D

    1. Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels.
      D Y Li, D Abran, K G Peri, D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 370-377;

  2. Adams, M

    1. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
      R C Pierce, B Born, M Adams and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 384-392;

  3. Akasaka, K

    1. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
      T Kagaya, A Kajiwara, S Nagato, K Akasaka and A Kubota
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 243-251;

  4. Aklillu, E

    1. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
      E Aklillu, I Persson, L Bertilsson, I Johansson, F Rodrigues and M Ingelman-Sundberg
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 441-446;

  5. Allain, H

    1. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
      E Bellissant, T Denolle, P Sinnassamy, D G Bichet, J F Giudicelli, F Lecoz, J M Gandon and H Allain
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 232-242;

  6. Allen, C N

    1. The sensitivity of N-methyl-D-aspartate receptors to lead inhibition is dependent on the receptor subunit composition.
      I A Omelchenko, C S Nelson, J L Marino and C N Allen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 15-20;

  7. Alling, C

    1. Long-term exposure to ethanol increases the number and function of muscarinic M1 receptors in human neuroblastoma cells.
      C Larsson, P Simonsson, M Caron and C Alling
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 313-319;

  8. Alloui, A

    1. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.
      T Pelissier, A Alloui, F Caussade, C Dubray, A Cloarec, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 8-14;

  9. Anderson, D C

    1. U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions.
      R J Smith, J M Justen, A R McNab, C L Rosenbloom, A N Steele, P A Detmers, D C Anderson and A M Manning
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 320-329;

  10. Arakawa, H

    1. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF.
      I Kawikova, H Arakawa, B E Skoogh, C G Löfdahl and J Lötvall
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 268-276;

  11. Armstrong, C T

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  12. Aungst, B J

    1. The secretory intestinal transport of some beta-lactam antibiotics and anionic compounds: a mechanism contributing to poor oral absorption.
      H Saitoh, C Gerard and B J Aungst
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 205-211;

  13. Aziz, S M

    1. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
      S M Aziz, M N Gillespie, P A Crooks, S F Tofiq, C P Tsuboi, J W Olson and M P Gosland
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 185-192;

B

  1. Bach, N J

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  2. Barsig, J

    1. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock.
      S Jilg, J Barsig, M Leist, S Küsters, H D Volk and A Wendel
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 421-431;

  3. Begany, D P

    1. Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.
      D P Begany, J A Carcillo, W A Herzer, Z Mi and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 37-41;

  4. Bellissant, E

    1. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
      E Bellissant, T Denolle, P Sinnassamy, D G Bichet, J F Giudicelli, F Lecoz, J M Gandon and H Allain
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 232-242;

  5. Berger, S P

    1. Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants.
      B K Tolliver, L B Ho, M S Reid and S P Berger
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 411-420;

  6. Bernstein, R N

    1. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
      T W Vanderah, R N Bernstein, H I Yamamura, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 212-219;

  7. Bertilsson, L

    1. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
      E Aklillu, I Persson, L Bertilsson, I Johansson, F Rodrigues and M Ingelman-Sundberg
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 441-446;

  8. Besson, J M

    1. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
      P Honoré, V Chapman, J Buritova and J M Besson
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 393-403;

  9. Bichet, D G

    1. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
      E Bellissant, T Denolle, P Sinnassamy, D G Bichet, J F Giudicelli, F Lecoz, J M Gandon and H Allain
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 232-242;

  10. Bickel, U

    1. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.
      U Bickel, O P Schumacher, Y S Kang and K Voigt
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 107-113;

  11. Blanco, I

    1. Conformationally biased analogs of human C5a mediate changes in vascular permeability.
      R Kawatsu, S D Sanderson, I Blanco, N Kendall, A M Finch, S M Taylor and D Colcher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 432-440;

  12. Bobbitt, J L

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  13. Born, B

    1. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
      R C Pierce, B Born, M Adams and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 384-392;

  14. Boulay, D

    1. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
      D Boulay, D Duterte-Boucher, I Leroux-Nicollet, L Naudon and J Costentin
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 330-337;

  15. Bradford, L

    1. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.
      T E Mertz, T B McClanahan, M A Flynn, P Juneau, E E Reynolds, H Hallak, L Bradford and K P Gallagher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 42-49;

  16. Breese, G R

    1. Evidence for a selective effect of ethanol on N-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitive N-methyl-d-aspartate receptors.
      X Yang, H E Criswell, P Simson, S Moy and G R Breese
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 114-124;

  17. Bruelle, P

    1. Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts.
      E Robert, P Bruelle, J E de La Coussaye, J M Juan, J Brugada, P Peray, M Dauzat and J J Eledjam
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 170-178;

  18. Brugada, J

    1. Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts.
      E Robert, P Bruelle, J E de La Coussaye, J M Juan, J Brugada, P Peray, M Dauzat and J J Eledjam
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 170-178;

  19. Buritova, J

    1. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
      P Honoré, V Chapman, J Buritova and J M Besson
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 393-403;

C

  1. Calixto, J B

    1. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice.
      Z R Vaz, V C Filho, R A Yunes and J B Calixto
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 304-312;

  2. Carcillo, J A

    1. Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.
      D P Begany, J A Carcillo, W A Herzer, Z Mi and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 37-41;

  3. Caron, M

    1. Long-term exposure to ethanol increases the number and function of muscarinic M1 receptors in human neuroblastoma cells.
      C Larsson, P Simonsson, M Caron and C Alling
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 313-319;

  4. Caussade, F

    1. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.
      T Pelissier, A Alloui, F Caussade, C Dubray, A Cloarec, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 8-14;

  5. Chapman, V

    1. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
      P Honoré, V Chapman, J Buritova and J M Besson
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 393-403;

  6. Chemtob, S

    1. Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels.
      D Y Li, D Abran, K G Peri, D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 370-377;

  7. Cheng, C C

    1. Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.
      B Levant, J D Moehlenkamp, K A Morgan, N L Leonard and C C Cheng
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 145-153;

  8. Chiba, K

    1. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
      E Koyama, K Chiba, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 21-30;

  9. Chuang, D M

    1. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture.
      R Ishitani, M Kimura, K Sunaga, N Katsube, M Tanaka and D M Chuang
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 447-454;

  10. Cloarec, A

    1. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.
      T Pelissier, A Alloui, F Caussade, C Dubray, A Cloarec, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 8-14;

  11. Colcher, D

    1. Conformationally biased analogs of human C5a mediate changes in vascular permeability.
      R Kawatsu, S D Sanderson, I Blanco, N Kendall, A M Finch, S M Taylor and D Colcher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 432-440;

  12. Collins, A C

    1. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
      J R Pauly, M J Marks, S F Robinson, J L van de Kamp and A C Collins
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 361-369;

  13. Cook, J J

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  14. Cooke, E S

    1. Cocaine-induced sensitization of metabolic activity in extrapyramidal circuits involves prior dopamine D1-like receptor stimulation.
      W L Thomas, E S Cooke and R P Hammer
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 347-353;

  15. Costentin, J

    1. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
      D Boulay, D Duterte-Boucher, I Leroux-Nicollet, L Naudon and J Costentin
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 330-337;

  16. Courogen, P M

    1. Contrasting effects of anesthetics in tadpole bioassays.
      H Downes and P M Courogen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 284-296;

  17. Criswell, H E

    1. Evidence for a selective effect of ethanol on N-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitive N-methyl-d-aspartate receptors.
      X Yang, H E Criswell, P Simson, S Moy and G R Breese
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 114-124;

  18. Crooks, P A

    1. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
      S M Aziz, M N Gillespie, P A Crooks, S F Tofiq, C P Tsuboi, J W Olson and M P Gosland
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 185-192;

D

  1. Dauzat, M

    1. Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts.
      E Robert, P Bruelle, J E de La Coussaye, J M Juan, J Brugada, P Peray, M Dauzat and J J Eledjam
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 170-178;

  2. Davis, J M

    1. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
      J M Pearson, A E Schultze, K A Schwartz, M A Scott, J M Davis and R A Roth
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 378-383;

  3. de La Coussaye, J E

    1. Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts.
      E Robert, P Bruelle, J E de La Coussaye, J M Juan, J Brugada, P Peray, M Dauzat and J J Eledjam
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 170-178;

  4. Denolle, T

    1. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
      E Bellissant, T Denolle, P Sinnassamy, D G Bichet, J F Giudicelli, F Lecoz, J M Gandon and H Allain
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 232-242;

  5. Detmers, P A

    1. U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions.
      R J Smith, J M Justen, A R McNab, C L Rosenbloom, A N Steele, P A Detmers, D C Anderson and A M Manning
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 320-329;

  6. Diehl, A M

    1. Ethanol exposure alters the phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element binding activity in rat cerebellum.
      X Yang, A M Diehl and G S Wand
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 338-346;

  7. Dillard, R D

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  8. Dokhan, R

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  9. Downes, H

    1. Contrasting effects of anesthetics in tadpole bioassays.
      H Downes and P M Courogen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 284-296;

  10. Drag, M D

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  11. Draheim, S

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  12. Dubray, C

    1. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.
      T Pelissier, A Alloui, F Caussade, C Dubray, A Cloarec, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 8-14;

  13. Duggan, M E

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  14. Duterte-Boucher, D

    1. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
      D Boulay, D Duterte-Boucher, I Leroux-Nicollet, L Naudon and J Costentin
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 330-337;

E

  1. Eledjam, J J

    1. Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts.
      E Robert, P Bruelle, J E de La Coussaye, J M Juan, J Brugada, P Peray, M Dauzat and J J Eledjam
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 170-178;

  2. Eschalier, A

    1. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.
      T Pelissier, A Alloui, F Caussade, C Dubray, A Cloarec, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 8-14;

F

  1. Filho, V C

    1. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice.
      Z R Vaz, V C Filho, R A Yunes and J B Calixto
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 304-312;

  2. Finch, A M

    1. Conformationally biased analogs of human C5a mediate changes in vascular permeability.
      R Kawatsu, S D Sanderson, I Blanco, N Kendall, A M Finch, S M Taylor and D Colcher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 432-440;

  3. Fink, G D

    1. Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin-converting enzyme inhibitors in renovascular hypertension.
      M G Melaragno and G D Fink
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 297-303;

  4. Fleisch, J H

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  5. Flynn, M A

    1. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.
      T E Mertz, T B McClanahan, M A Flynn, P Juneau, E E Reynolds, H Hallak, L Bradford and K P Gallagher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 42-49;

  6. Folsch, U R

    1. Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.
      S Katsoulis, W E Schmidt, R Schwarzhoff, U R Folsch, J G Jin, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 199-204;

  7. Fouts, R

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  8. Fritzsch, G

    1. Stereospecificity in contraluminal and luminal transporters of organic cations in the rat renal proximal tubule.
      A A Somogyi, G Rumrich, G Fritzsch and K J Ullrich
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 31-36;

  9. Fukuizumi, Y

    1. The effects of calcitonin gene-related peptide on the cytosolic calcium concentration and force in the porcine coronary artery.
      Y Fukuizumi, S Kobayashi, J Nishimura and H Kanaide
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 220-231;

G

  1. Gallagher, K P

    1. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.
      T E Mertz, T B McClanahan, M A Flynn, P Juneau, E E Reynolds, H Hallak, L Bradford and K P Gallagher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 42-49;

  2. Gandon, J M

    1. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
      E Bellissant, T Denolle, P Sinnassamy, D G Bichet, J F Giudicelli, F Lecoz, J M Gandon and H Allain
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 232-242;

  3. Gebhart, G F

    1. Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat.
      M O Urban, D J Smith and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 90-96;

  4. Gehret, J R

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  5. Gerard, C

    1. The secretory intestinal transport of some beta-lactam antibiotics and anionic compounds: a mechanism contributing to poor oral absorption.
      H Saitoh, C Gerard and B J Aungst
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 205-211;

  6. Gillespie, M N

    1. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
      S M Aziz, M N Gillespie, P A Crooks, S F Tofiq, C P Tsuboi, J W Olson and M P Gosland
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 185-192;

  7. Giudicelli, J F

    1. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
      E Bellissant, T Denolle, P Sinnassamy, D G Bichet, J F Giudicelli, F Lecoz, J M Gandon and H Allain
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 232-242;

  8. Godfroid, J J

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  9. Goetz, A S

    1. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.
      D L Saussy, A S Goetz, K L Queen, H K King, M W Lutz and T J Rimele
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 136-144;

  10. Gosland, M P

    1. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
      S M Aziz, M N Gillespie, P A Crooks, S F Tofiq, C P Tsuboi, J W Olson and M P Gosland
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 185-192;

  11. Gould, R J

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  12. Grider, J R

    1. Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.
      S Katsoulis, W E Schmidt, R Schwarzhoff, U R Folsch, J G Jin, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 199-204;

  13. Guardiola-Lemaitre, B

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

H

  1. Hallak, H

    1. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.
      T E Mertz, T B McClanahan, M A Flynn, P Juneau, E E Reynolds, H Hallak, L Bradford and K P Gallagher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 42-49;

  2. Hammer, R P

    1. Cocaine-induced sensitization of metabolic activity in extrapyramidal circuits involves prior dopamine D1-like receptor stimulation.
      W L Thomas, E S Cooke and R P Hammer
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 347-353;

  3. Hand, E L

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  4. Hardwick, W C

    1. Effects of drug discrimination history on the generalization of pentobarbital to other drugs.
      D E McMillan, W L Sun and W C Hardwick
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 50-61;

  5. Hartman, G D

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  6. Herzer, W A

    1. Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.
      D P Begany, J A Carcillo, W A Herzer, Z Mi and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 37-41;

  7. Higuchi, S

    1. Influence of feeding schedule on the chronopharmacological aspects of sodium valproate in mice.
      S Ohdo, N Ogawa, S Nakano and S Higuchi
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 74-81;

  8. Ho, L B

    1. Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants.
      B K Tolliver, L B Ho, M S Reid and S P Berger
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 411-420;

  9. Holahan, M A

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  10. Honoré, P

    1. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
      P Honoré, V Chapman, J Buritova and J M Besson
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 393-403;

  11. Hruby, V J

    1. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
      T W Vanderah, R N Bernstein, H I Yamamura, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 212-219;

I

  1. Ihle, N C

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  2. Ingelman-Sundberg, M

    1. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
      E Aklillu, I Persson, L Bertilsson, I Johansson, F Rodrigues and M Ingelman-Sundberg
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 441-446;

  3. Ishitani, R

    1. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture.
      R Ishitani, M Kimura, K Sunaga, N Katsube, M Tanaka and D M Chuang
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 447-454;

  4. Ishizaki, T

    1. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
      E Koyama, K Chiba, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 21-30;

J

  1. Jackson, E K

    1. Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.
      D P Begany, J A Carcillo, W A Herzer, Z Mi and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 37-41;

  2. Jackson, W T

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  3. Jacoby, H I

    1. Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic model.
      R B Raffa, J J Schupsky, D K Lee and H I Jacoby
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 1-7;

  4. Jilg, S

    1. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock.
      S Jilg, J Barsig, M Leist, S Küsters, H D Volk and A Wendel
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 421-431;

  5. Jin, J G

    1. Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.
      S Katsoulis, W E Schmidt, R Schwarzhoff, U R Folsch, J G Jin, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 199-204;

  6. Johansson, I

    1. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
      E Aklillu, I Persson, L Bertilsson, I Johansson, F Rodrigues and M Ingelman-Sundberg
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 441-446;

  7. Juan, J M

    1. Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts.
      E Robert, P Bruelle, J E de La Coussaye, J M Juan, J Brugada, P Peray, M Dauzat and J J Eledjam
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 170-178;

  8. Juneau, P

    1. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.
      T E Mertz, T B McClanahan, M A Flynn, P Juneau, E E Reynolds, H Hallak, L Bradford and K P Gallagher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 42-49;

  9. Junien, J L

    1. Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum.
      R K Rao, Y Lopez, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 193-198;

  10. Justen, J M

    1. U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions.
      R J Smith, J M Justen, A R McNab, C L Rosenbloom, A N Steele, P A Detmers, D C Anderson and A M Manning
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 320-329;

K

  1. Kagaya, T

    1. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
      T Kagaya, A Kajiwara, S Nagato, K Akasaka and A Kubota
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 243-251;

  2. Kajiwara, A

    1. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
      T Kagaya, A Kajiwara, S Nagato, K Akasaka and A Kubota
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 243-251;

  3. Kalivas, P W

    1. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
      R C Pierce, B Born, M Adams and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 384-392;

  4. Kamerling, S G

    1. Evaluation of detomidine-induced analgesia in horses with chronic hoof pain.
      J G Owens, S G Kamerling, S R Stanton and M L Keowen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 179-184;

  5. Kanaide, H

    1. The effects of calcitonin gene-related peptide on the cytosolic calcium concentration and force in the porcine coronary artery.
      Y Fukuizumi, S Kobayashi, J Nishimura and H Kanaide
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 220-231;

  6. Kang, Y S

    1. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.
      U Bickel, O P Schumacher, Y S Kang and K Voigt
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 107-113;

  7. Katsoulis, S

    1. Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.
      S Katsoulis, W E Schmidt, R Schwarzhoff, U R Folsch, J G Jin, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 199-204;

  8. Katsube, N

    1. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture.
      R Ishitani, M Kimura, K Sunaga, N Katsube, M Tanaka and D M Chuang
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 447-454;

  9. Kawatsu, R

    1. Conformationally biased analogs of human C5a mediate changes in vascular permeability.
      R Kawatsu, S D Sanderson, I Blanco, N Kendall, A M Finch, S M Taylor and D Colcher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 432-440;

  10. Kawikova, I

    1. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF.
      I Kawikova, H Arakawa, B E Skoogh, C G Löfdahl and J Lötvall
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 268-276;

  11. Kendall, N

    1. Conformationally biased analogs of human C5a mediate changes in vascular permeability.
      R Kawatsu, S D Sanderson, I Blanco, N Kendall, A M Finch, S M Taylor and D Colcher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 432-440;

  12. Keowen, M L

    1. Evaluation of detomidine-induced analgesia in horses with chronic hoof pain.
      J G Owens, S G Kamerling, S R Stanton and M L Keowen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 179-184;

  13. Khan, I M

    1. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats.
      I M Khan, M Marsala, M P Printz, P Taylor and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 97-106;

  14. Kimura, M

    1. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture.
      R Ishitani, M Kimura, K Sunaga, N Katsube, M Tanaka and D M Chuang
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 447-454;

  15. King, H K

    1. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.
      D L Saussy, A S Goetz, K L Queen, H K King, M W Lutz and T J Rimele
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 136-144;

  16. Kobayashi, S

    1. The effects of calcitonin gene-related peptide on the cytosolic calcium concentration and force in the porcine coronary artery.
      Y Fukuizumi, S Kobayashi, J Nishimura and H Kanaide
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 220-231;

  17. Kothstein, T

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  18. Koyama, E

    1. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
      E Koyama, K Chiba, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 21-30;

  19. Ktorza, A

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  20. Kubota, A

    1. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
      T Kagaya, A Kajiwara, S Nagato, K Akasaka and A Kubota
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 243-251;

  21. Küsters, S

    1. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock.
      S Jilg, J Barsig, M Leist, S Küsters, H D Volk and A Wendel
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 421-431;

L

  1. Lamouri, A

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  2. Larsson, C

    1. Long-term exposure to ethanol increases the number and function of muscarinic M1 receptors in human neuroblastoma cells.
      C Larsson, P Simonsson, M Caron and C Alling
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 313-319;

  3. Lavarenne, J

    1. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.
      T Pelissier, A Alloui, F Caussade, C Dubray, A Cloarec, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 8-14;

  4. Lecoz, F

    1. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
      E Bellissant, T Denolle, P Sinnassamy, D G Bichet, J F Giudicelli, F Lecoz, J M Gandon and H Allain
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 232-242;

  5. Lee, D K

    1. Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic model.
      R B Raffa, J J Schupsky, D K Lee and H I Jacoby
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 1-7;

  6. Leist, M

    1. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock.
      S Jilg, J Barsig, M Leist, S Küsters, H D Volk and A Wendel
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 421-431;

  7. Leonard, N L

    1. Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.
      B Levant, J D Moehlenkamp, K A Morgan, N L Leonard and C C Cheng
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 145-153;

  8. Leroux-Nicollet, I

    1. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
      D Boulay, D Duterte-Boucher, I Leroux-Nicollet, L Naudon and J Costentin
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 330-337;

  9. Levant, B

    1. Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.
      B Levant, J D Moehlenkamp, K A Morgan, N L Leonard and C C Cheng
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 145-153;

  10. Li, D Y

    1. Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels.
      D Y Li, D Abran, K G Peri, D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 370-377;

  11. Lin, Q

    1. Involvement of alpha-2 adrenoceptors in the periaqueductal gray-induced inhibition of dorsal horn cell activity in rats.
      Y B Peng, Q Lin and W D Willis
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 125-135;

  12. Liu, J H

    1. Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins.
      J H Liu, R S Malone, H Stallings and P C Smith
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 277-283;

  13. Löfdahl, C G

    1. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF.
      I Kawikova, H Arakawa, B E Skoogh, C G Löfdahl and J Lötvall
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 268-276;

  14. Lopez, Y

    1. Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum.
      R K Rao, Y Lopez, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 193-198;

  15. Lötvall, J

    1. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF.
      I Kawikova, H Arakawa, B E Skoogh, C G Löfdahl and J Lötvall
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 268-276;

  16. Lutz, M W

    1. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.
      D L Saussy, A S Goetz, K L Queen, H K King, M W Lutz and T J Rimele
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 136-144;

  17. Lyle, E A

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  18. Lynch, J J

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

M

  1. Makhlouf, G M

    1. Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.
      S Katsoulis, W E Schmidt, R Schwarzhoff, U R Folsch, J G Jin, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 199-204;

  2. Malberg, J E

    1. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.
      J E Malberg, K E Sabol and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 258-267;

  3. Malone, R S

    1. Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins.
      J H Liu, R S Malone, H Stallings and P C Smith
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 277-283;

  4. Manechez, D

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  5. Manning, A M

    1. U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions.
      R J Smith, J M Justen, A R McNab, C L Rosenbloom, A N Steele, P A Detmers, D C Anderson and A M Manning
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 320-329;

  6. Marc, S

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  7. Marino, J L

    1. The sensitivity of N-methyl-D-aspartate receptors to lead inhibition is dependent on the receptor subunit composition.
      I A Omelchenko, C S Nelson, J L Marino and C N Allen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 15-20;

  8. Marks, M J

    1. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
      J R Pauly, M J Marks, S F Robinson, J L van de Kamp and A C Collins
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 361-369;

  9. Marsala, M

    1. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats.
      I M Khan, M Marsala, M P Printz, P Taylor and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 97-106;

  10. Martin, C L

    1. Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol.
      C L Martin, M A Palomo and E G Mcmahon
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 154-162;

  11. Martinelli, M

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  12. McClanahan, T B

    1. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.
      T E Mertz, T B McClanahan, M A Flynn, P Juneau, E E Reynolds, H Hallak, L Bradford and K P Gallagher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 42-49;

  13. McCormick, G Y

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  14. Mcmahon, E G

    1. Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol.
      C L Martin, M A Palomo and E G Mcmahon
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 154-162;

  15. McMillan, D E

    1. Effects of drug discrimination history on the generalization of pentobarbital to other drugs.
      D E McMillan, W L Sun and W C Hardwick
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 50-61;

  16. McNab, A R

    1. U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions.
      R J Smith, J M Justen, A R McNab, C L Rosenbloom, A N Steele, P A Detmers, D C Anderson and A M Manning
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 320-329;

  17. Melaragno, M G

    1. Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin-converting enzyme inhibitors in renovascular hypertension.
      M G Melaragno and G D Fink
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 297-303;

  18. Mertz, T E

    1. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.
      T E Mertz, T B McClanahan, M A Flynn, P Juneau, E E Reynolds, H Hallak, L Bradford and K P Gallagher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 42-49;

  19. Mi, Z

    1. Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.
      D P Begany, J A Carcillo, W A Herzer, Z Mi and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 37-41;

  20. Mihelich, E D

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  21. Moehlenkamp, J D

    1. Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.
      B Levant, J D Moehlenkamp, K A Morgan, N L Leonard and C C Cheng
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 145-153;

  22. Morgan, K A

    1. Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.
      B Levant, J D Moehlenkamp, K A Morgan, N L Leonard and C C Cheng
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 145-153;

  23. Moy, S

    1. Evidence for a selective effect of ethanol on N-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitive N-methyl-d-aspartate receptors.
      X Yang, H E Criswell, P Simson, S Moy and G R Breese
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 114-124;

N

  1. Nagato, S

    1. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
      T Kagaya, A Kajiwara, S Nagato, K Akasaka and A Kubota
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 243-251;

  2. Nakano, S

    1. Influence of feeding schedule on the chronopharmacological aspects of sodium valproate in mice.
      S Ohdo, N Ogawa, S Nakano and S Higuchi
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 74-81;

  3. Naudon, L

    1. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
      D Boulay, D Duterte-Boucher, I Leroux-Nicollet, L Naudon and J Costentin
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 330-337;

  4. Nelson, C S

    1. The sensitivity of N-methyl-D-aspartate receptors to lead inhibition is dependent on the receptor subunit composition.
      I A Omelchenko, C S Nelson, J L Marino and C N Allen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 15-20;

  5. Nishimura, J

    1. The effects of calcitonin gene-related peptide on the cytosolic calcium concentration and force in the porcine coronary artery.
      Y Fukuizumi, S Kobayashi, J Nishimura and H Kanaide
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 220-231;

O

  1. O'Hara, C M

    1. Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
      C M O'Hara, L Tang, R Taussig, R D Todd and K L O'Malley
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 354-360;

  2. O'Malley, K L

    1. Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
      C M O'Hara, L Tang, R Taussig, R D Todd and K L O'Malley
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 354-360;

  3. Ogawa, N

    1. Influence of feeding schedule on the chronopharmacological aspects of sodium valproate in mice.
      S Ohdo, N Ogawa, S Nakano and S Higuchi
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 74-81;

  4. Ohdo, S

    1. Influence of feeding schedule on the chronopharmacological aspects of sodium valproate in mice.
      S Ohdo, N Ogawa, S Nakano and S Higuchi
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 74-81;

  5. Olson, J W

    1. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
      S M Aziz, M N Gillespie, P A Crooks, S F Tofiq, C P Tsuboi, J W Olson and M P Gosland
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 185-192;

  6. Omelchenko, I A

    1. The sensitivity of N-methyl-D-aspartate receptors to lead inhibition is dependent on the receptor subunit composition.
      I A Omelchenko, C S Nelson, J L Marino and C N Allen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 15-20;

  7. Owens, J G

    1. Evaluation of detomidine-induced analgesia in horses with chronic hoof pain.
      J G Owens, S G Kamerling, S R Stanton and M L Keowen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 179-184;

P

  1. Palomo, M A

    1. Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol.
      C L Martin, M A Palomo and E G Mcmahon
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 154-162;

  2. Pascaud, X

    1. Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum.
      R K Rao, Y Lopez, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 193-198;

  3. Pauly, J R

    1. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
      J R Pauly, M J Marks, S F Robinson, J L van de Kamp and A C Collins
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 361-369;

  4. Pearson, J M

    1. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
      J M Pearson, A E Schultze, K A Schwartz, M A Scott, J M Davis and R A Roth
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 378-383;

  5. Pelissier, T

    1. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence.
      T Pelissier, A Alloui, F Caussade, C Dubray, A Cloarec, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 8-14;

  6. Peng, Y B

    1. Involvement of alpha-2 adrenoceptors in the periaqueductal gray-induced inhibition of dorsal horn cell activity in rats.
      Y B Peng, Q Lin and W D Willis
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 125-135;

  7. Pénicaud, L

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  8. Peray, P

    1. Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts.
      E Robert, P Bruelle, J E de La Coussaye, J M Juan, J Brugada, P Peray, M Dauzat and J J Eledjam
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 170-178;

  9. Peri, K G

    1. Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels.
      D Y Li, D Abran, K G Peri, D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 370-377;

  10. Perkins, J J

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  11. Persson, I

    1. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
      E Aklillu, I Persson, L Bertilsson, I Johansson, F Rodrigues and M Ingelman-Sundberg
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 441-446;

  12. Pfeiffer, B

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  13. Pierce, R C

    1. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
      R C Pierce, B Born, M Adams and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 384-392;

  14. Porreca, F

    1. Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum.
      R K Rao, Y Lopez, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 193-198;
    2. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
      T W Vanderah, R N Bernstein, H I Yamamura, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 212-219;

  15. Printz, M P

    1. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats.
      I M Khan, M Marsala, M P Printz, P Taylor and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 97-106;

Q

  1. Queen, K L

    1. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.
      D L Saussy, A S Goetz, K L Queen, H K King, M W Lutz and T J Rimele
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 136-144;

R

  1. Raffa, R B

    1. Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic model.
      R B Raffa, J J Schupsky, D K Lee and H I Jacoby
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 1-7;

  2. Ramjit, D R

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  3. Rao, R K

    1. Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum.
      R K Rao, Y Lopez, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 193-198;

  4. Reid, M S

    1. Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants.
      B K Tolliver, L B Ho, M S Reid and S P Berger
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 411-420;

  5. Renard, P

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  6. Reynolds, E E

    1. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.
      T E Mertz, T B McClanahan, M A Flynn, P Juneau, E E Reynolds, H Hallak, L Bradford and K P Gallagher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 42-49;

  7. Rimele, T J

    1. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.
      D L Saussy, A S Goetz, K L Queen, H K King, M W Lutz and T J Rimele
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 136-144;

  8. Riviere, P J

    1. Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum.
      R K Rao, Y Lopez, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 193-198;

  9. Robert, E

    1. Electrophysiologic and proarrhythmogenic effects of therapeutic and toxic doses of imipramine: a study with high resolution ventricular epicardial mapping in rabbit hearts.
      E Robert, P Bruelle, J E de La Coussaye, J M Juan, J Brugada, P Peray, M Dauzat and J J Eledjam
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 170-178;

  10. Robinson, S F

    1. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
      J R Pauly, M J Marks, S F Robinson, J L van de Kamp and A C Collins
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 361-369;

  11. Rodrigues, F

    1. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
      E Aklillu, I Persson, L Bertilsson, I Johansson, F Rodrigues and M Ingelman-Sundberg
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 441-446;

  12. Rodriguez-Farré, E

    1. Cytotoxicity of hexachlorocyclohexane isomers and cyclodienes in primary cultures of cerebellar granule cells.
      R Rosa, E Rodriguez-Farré and C Sanfeliu
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 163-169;

  13. Roman, C R

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  14. Rondu, F

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  15. Rosa, R

    1. Cytotoxicity of hexachlorocyclohexane isomers and cyclodienes in primary cultures of cerebellar granule cells.
      R Rosa, E Rodriguez-Farré and C Sanfeliu
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 163-169;

  16. Rosenbloom, C L

    1. U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions.
      R J Smith, J M Justen, A R McNab, C L Rosenbloom, A N Steele, P A Detmers, D C Anderson and A M Manning
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 320-329;

  17. Roth, R A

    1. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
      J M Pearson, A E Schultze, K A Schwartz, M A Scott, J M Davis and R A Roth
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 378-383;

  18. Rumrich, G

    1. Stereospecificity in contraluminal and luminal transporters of organic cations in the rat renal proximal tubule.
      A A Somogyi, G Rumrich, G Fritzsch and K J Ullrich
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 31-36;

S

  1. Sabol, K E

    1. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.
      J E Malberg, K E Sabol and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 258-267;

  2. Saitoh, H

    1. The secretory intestinal transport of some beta-lactam antibiotics and anionic compounds: a mechanism contributing to poor oral absorption.
      H Saitoh, C Gerard and B J Aungst
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 205-211;

  3. Sanderson, S D

    1. Conformationally biased analogs of human C5a mediate changes in vascular permeability.
      R Kawatsu, S D Sanderson, I Blanco, N Kendall, A M Finch, S M Taylor and D Colcher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 432-440;

  4. Sanfeliu, C

    1. Cytotoxicity of hexachlorocyclohexane isomers and cyclodienes in primary cultures of cerebellar granule cells.
      R Rosa, E Rodriguez-Farré and C Sanfeliu
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 163-169;

  5. Saussy, D L

    1. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype.
      D L Saussy, A S Goetz, K L Queen, H K King, M W Lutz and T J Rimele
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 136-144;

  6. Schmidt, W E

    1. Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.
      S Katsoulis, W E Schmidt, R Schwarzhoff, U R Folsch, J G Jin, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 199-204;

  7. Schultze, A E

    1. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
      J M Pearson, A E Schultze, K A Schwartz, M A Scott, J M Davis and R A Roth
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 378-383;

  8. Schumacher, O P

    1. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.
      U Bickel, O P Schumacher, Y S Kang and K Voigt
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 107-113;

  9. Schupsky, J J

    1. Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic model.
      R B Raffa, J J Schupsky, D K Lee and H I Jacoby
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 1-7;

  10. Schwartz, K A

    1. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
      J M Pearson, A E Schultze, K A Schwartz, M A Scott, J M Davis and R A Roth
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 378-383;

  11. Schwarzhoff, R

    1. Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.
      S Katsoulis, W E Schmidt, R Schwarzhoff, U R Folsch, J G Jin, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 199-204;

  12. Scott, M A

    1. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
      J M Pearson, A E Schultze, K A Schwartz, M A Scott, J M Davis and R A Roth
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 378-383;

  13. Seiden, L S

    1. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.
      J E Malberg, K E Sabol and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 258-267;

  14. Simonsson, P

    1. Long-term exposure to ethanol increases the number and function of muscarinic M1 receptors in human neuroblastoma cells.
      C Larsson, P Simonsson, M Caron and C Alling
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 313-319;

  15. Simson, P

    1. Evidence for a selective effect of ethanol on N-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitive N-methyl-d-aspartate receptors.
      X Yang, H E Criswell, P Simson, S Moy and G R Breese
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 114-124;

  16. Sinnassamy, P

    1. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
      E Bellissant, T Denolle, P Sinnassamy, D G Bichet, J F Giudicelli, F Lecoz, J M Gandon and H Allain
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 232-242;

  17. Sitko, G R

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  18. Skoogh, B E

    1. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF.
      I Kawikova, H Arakawa, B E Skoogh, C G Löfdahl and J Lötvall
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 268-276;

  19. Smith, D J

    1. Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat.
      M O Urban, D J Smith and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 90-96;

  20. Smith, P C

    1. Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins.
      J H Liu, R S Malone, H Stallings and P C Smith
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 277-283;

  21. Smith, R J

    1. U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions.
      R J Smith, J M Justen, A R McNab, C L Rosenbloom, A N Steele, P A Detmers, D C Anderson and A M Manning
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 320-329;

  22. Snyder, D W

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  23. Somogyi, A A

    1. Stereospecificity in contraluminal and luminal transporters of organic cations in the rat renal proximal tubule.
      A A Somogyi, G Rumrich, G Fritzsch and K J Ullrich
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 31-36;

  24. Spaethe, S M

    1. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
      J H Fleisch, C T Armstrong, C R Roman, E D Mihelich, S M Spaethe, W T Jackson, J L Bobbitt, S Draheim, N J Bach, R D Dillard, M Martinelli, R Fouts and D W Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 252-257;

  25. Stallings, H

    1. Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins.
      J H Liu, R S Malone, H Stallings and P C Smith
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 277-283;

  26. Stanton, S R

    1. Evaluation of detomidine-induced analgesia in horses with chronic hoof pain.
      J G Owens, S G Kamerling, S R Stanton and M L Keowen
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 179-184;

  27. Steele, A N

    1. U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions.
      R J Smith, J M Justen, A R McNab, C L Rosenbloom, A N Steele, P A Detmers, D C Anderson and A M Manning
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 320-329;

  28. Stranieri, M T

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  29. Stupienski, R F

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  30. Sun, W L

    1. Effects of drug discrimination history on the generalization of pentobarbital to other drugs.
      D E McMillan, W L Sun and W C Hardwick
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 50-61;

  31. Sunaga, K

    1. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture.
      R Ishitani, M Kimura, K Sunaga, N Katsube, M Tanaka and D M Chuang
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 447-454;

  32. Swoveland, P

    1. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat.
      W J Wojcik, P Swoveland, X Zhang and P Vanguri
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 404-410;

T

  1. Tanaka, M

    1. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture.
      R Ishitani, M Kimura, K Sunaga, N Katsube, M Tanaka and D M Chuang
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 447-454;

  2. Tang, L

    1. Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
      C M O'Hara, L Tang, R Taussig, R D Todd and K L O'Malley
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 354-360;

  3. Tani, M

    1. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
      E Koyama, K Chiba, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 21-30;

  4. Taussig, R

    1. Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
      C M O'Hara, L Tang, R Taussig, R D Todd and K L O'Malley
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 354-360;

  5. Taylor, P

    1. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats.
      I M Khan, M Marsala, M P Printz, P Taylor and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 97-106;

  6. Taylor, S M

    1. Conformationally biased analogs of human C5a mediate changes in vascular permeability.
      R Kawatsu, S D Sanderson, I Blanco, N Kendall, A M Finch, S M Taylor and D Colcher
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 432-440;

  7. Thomas, W L

    1. Cocaine-induced sensitization of metabolic activity in extrapyramidal circuits involves prior dopamine D1-like receptor stimulation.
      W L Thomas, E S Cooke and R P Hammer
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 347-353;

  8. Todd, R D

    1. Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
      C M O'Hara, L Tang, R Taussig, R D Todd and K L O'Malley
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 354-360;

  9. Tofiq, S F

    1. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
      S M Aziz, M N Gillespie, P A Crooks, S F Tofiq, C P Tsuboi, J W Olson and M P Gosland
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 185-192;

  10. Tolliver, B K

    1. Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants.
      B K Tolliver, L B Ho, M S Reid and S P Berger
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 411-420;

  11. Touboul, E

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  12. Tsuboi, C P

    1. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
      S M Aziz, M N Gillespie, P A Crooks, S F Tofiq, C P Tsuboi, J W Olson and M P Gosland
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 185-192;

U

  1. Ullrich, K J

    1. Stereospecificity in contraluminal and luminal transporters of organic cations in the rat renal proximal tubule.
      A A Somogyi, G Rumrich, G Fritzsch and K J Ullrich
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 31-36;

  2. Urban, M O

    1. Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat.
      M O Urban, D J Smith and G F Gebhart
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 90-96;

V

  1. van de Kamp, J L

    1. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
      J R Pauly, M J Marks, S F Robinson, J L van de Kamp and A C Collins
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 361-369;

  2. Vanderah, T W

    1. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
      T W Vanderah, R N Bernstein, H I Yamamura, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 212-219;

  3. Vanguri, P

    1. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat.
      W J Wojcik, P Swoveland, X Zhang and P Vanguri
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 404-410;

  4. Varma, D R

    1. Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels.
      D Y Li, D Abran, K G Peri, D R Varma and S Chemtob
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 370-377;

  5. Vaz, Z R

    1. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice.
      Z R Vaz, V C Filho, R A Yunes and J B Calixto
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 304-312;

  6. Voigt, K

    1. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.
      U Bickel, O P Schumacher, Y S Kang and K Voigt
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 107-113;

  7. Volk, H D

    1. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock.
      S Jilg, J Barsig, M Leist, S Küsters, H D Volk and A Wendel
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 421-431;

W

  1. Wallace, A A

    1. Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
      J J Cook, M A Holahan, E A Lyle, D R Ramjit, G R Sitko, M T Stranieri, R F Stupienski, A A Wallace, E L Hand, J R Gehret, T Kothstein, M D Drag, G Y McCormick, J J Perkins, N C Ihle, M E Duggan, G D Hartman, R J Gould and J J Lynch
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 62-73;

  2. Wand, G S

    1. Ethanol exposure alters the phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element binding activity in rat cerebellum.
      X Yang, A M Diehl and G S Wand
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 338-346;

  3. Wang, X

    1. Effect of S-21663 (PMS 812), an imidazoline derivative, on glucose tolerance and insulin secretion in a rat model of type II diabetes.
      X Wang, F Rondu, A Lamouri, R Dokhan, S Marc, E Touboul, B Pfeiffer, D Manechez, P Renard, B Guardiola-Lemaitre, J J Godfroid, A Ktorza and L Pénicaud
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 82-89;

  4. Wendel, A

    1. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock.
      S Jilg, J Barsig, M Leist, S Küsters, H D Volk and A Wendel
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 421-431;

  5. Willis, W D

    1. Involvement of alpha-2 adrenoceptors in the periaqueductal gray-induced inhibition of dorsal horn cell activity in rats.
      Y B Peng, Q Lin and W D Willis
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 125-135;

  6. Wojcik, W J

    1. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat.
      W J Wojcik, P Swoveland, X Zhang and P Vanguri
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 404-410;

Y

  1. Yaksh, T L

    1. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats.
      I M Khan, M Marsala, M P Printz, P Taylor and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 97-106;

  2. Yamamura, H I

    1. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
      T W Vanderah, R N Bernstein, H I Yamamura, V J Hruby and F Porreca
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 212-219;

  3. Yang, X

    1. Evidence for a selective effect of ethanol on N-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitive N-methyl-d-aspartate receptors.
      X Yang, H E Criswell, P Simson, S Moy and G R Breese
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 114-124;
    2. Ethanol exposure alters the phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element binding activity in rat cerebellum.
      X Yang, A M Diehl and G S Wand
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 338-346;

  4. Yunes, R A

    1. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice.
      Z R Vaz, V C Filho, R A Yunes and J B Calixto
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 304-312;

Z

  1. Zhang, X

    1. Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat.
      W J Wojcik, P Swoveland, X Zhang and P Vanguri
      Journal of Pharmacology and Experimental Therapeutics July 1996, 278 (1) 404-410;
Back to top

In this issue